BIO-RAD LABORATORIES, INC. (BIO-B)

SEC filing

BIO-RAD LABORATORIES, INC.

BIO-B · CIK 12208

4 · Sep 9, 2026 · EVP, Chief Financial Officer Lakkaraju Roop Kalyan exercised options for 2,906 shares; reported 1,341 shares

EVP, Chief Financial Officer Lakkaraju Roop Kalyan exercised options for 2,906 shares; reported 1,341 shares

FORM 4

xslF345X06/wk-form4_1788993769.xmlSEC.gov

Graphics and non-inline formats (not embedded below).